|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8300 EUR | +36.07% |
|
+107.50% | +501.45% |
| 07-16 | Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies | MT |
| 07-16 | Valerio Therapeutics, Abivax Sign R&D Deal for Inflammatory Diseases' Drug Candidates | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VALERIO THERAPEUTICS | Other Pharmaceuticals | +36.07% | +107.50% | +501.45% | +1,420.15% | +37.65% | 473M |  | | |
- Stock Market
- Stocks
- ALVIO Stock
- Charts Valerio Therapeutics
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
